Proteros Obtains CIR Accreditation
News Jan 25, 2012
Proteros biostructures GmbH has announced that it has been awarded CIR accreditation by the French Ministry of Higher Education and Research.
The accreditation allows eligible French companies to benefit from significant tax relief (Crédit d'Impôt sur la Recherche) on research carried out by Proteros on their behalf until 2013.
“We are very pleased that our French clients will be able to benefit from the CIR accreditation and the opportunity to receive 30% of their R&D costs in tax credits” said Gordon Woodrow, EVP Strategic Alliances.
Woodrow continued, “Proteros’ clients can access services that range from protein crystallography, kinetic/thermodynamic profiling and custom proteins to fully integrated structure-based lead discovery including proprietary protein-inspired fragment libraries and medicinal chemistry.”
With their ability to treat a wide a variety of diseases, spherical nucleic acids are poised to revolutionize medicine. But before these digitally designed nanostructures can reach their full potential, researchers need to optimize their various components. A team has developed a direct route to optimize these particles, bringing them one step closer to becoming a viable treatment option for numerous diseases, including cancer.READ MORE